Abstract
Introduction

Angioimmunoblastic T-cell lymphoma (AITL) is a lymphoproliferative disorder first described in 1974 (1). Patients are generally in their sixth or seventh decade of life and present with fever, night sweats, weight loss, pruritus, generalized lymphadenopathy, and often hepatosplenomegaly and skin rash (2, 3). The disease is currently classified as a subtype of peripheral T-cell lymphoma (3); however, the lymphoma cells are not readily identifiable and the histological features of affected lymph nodes may suggest a reactive process. Nevertheless, immunohistochemical examination reveals neoplastic T-cells around high-endothelial venules (3), and subsets of phenotypically aberrant T-cells are present consistently in nearly all cases of AITL (4).
Although generalized lymphadenopathy is the main presenting sign of AITL, many patients have evidence of extranodal involvement at the time of diagnosis (2) He ma t o l o g i c a l a n d I mmu n o l o g i c a l L a b o r a t o (Fig. 2, e) . Immunostaining against the latent membrane protein 1 of Epstein-Barr virus was negative.
Characterization of circulating lymphocytes
Examination of peripheral blood smears disclosed atypical lymphocytes comprising up to 10% of nucleated cells. The cells ranged from lymphoplasmacytic cells (Fig. 3A, a and b ) through large blasts containing apparent nucleoli (Fig. 3A, c through f) (Fig. 4) , indicating florid lymphoma of T-cell phenotype. Ap p e a r a n c e o f t h e b o n e ma r r o w b i o p s y ( H&E s t a i n i n g ) . Or i g i n a l ma g n i f i c a t i o n s : a , × 1 0 0 ; b , × 4 0 0 . F i g u r e 4 . P o s t mo r t e m a p p e a r a n c e o f t h e l y mp h n o d e ( H&E s t a i n i n g ) . I mmn u n o h i s t o c h e mi s t r y  f o r CD4 5 RO i s s h o wn i n t h e i n s e t o f b . B a r = 1 0 0 μ m ( a ) o r 1 0 μ m ( b ) . (2, 3) . The neoplastic T-cells can express the CD10 antigen (2, 4, 6, 8, 9) (11) .
F i g u r e 2 . I mmu n o h i s t o c h e mi s t r y o f t h e b o n e ma r r o w. Co n s e c u t i v e s e c t i o n s we r e s t a i n e d wi t h a n t i -CD3 ( a , × 1 0 0 ) a n d a n t i -CD1 0 ( c , × 1 0 0 ) mo n o c l o n a l a n t i b o d i e s , a n d e a c h h i g h e r ma g n i f i c a t i o n ( × 4 0 0 ) i s s h o wn i n b a n d d , r e s p e c t i v e l y . CD7 9 a -p o s i t i v e c e l l s a r e s h o wn i n e ( × 4 0 0 ) .
F i g u r e 3 . Ch a r a c t e r i z a t i o n o f c i r c u l a t i n g l y mp h o c y t e s . ( A) Ma y -Gi e ms a -s t a i n e d a t y p i c a l l y mp h oc y t e s i n t h e p e r i p h e r a l b l o o d . Or i g i n a l ma g n i f i c a t i o n , × 1 , 0 0 0 . ( B ) F l o w c y t o me t r i c a n a l y s i s o f c i r c ul a t i n g l y mp h o c y t e s . F o r wa r d s c a t t e r ( F S C) a n d s i d e s c a t t e r ( S S C) c h a r a c t e r i s t i c s o f t h e p e r i p h e r a l b l o o d l e u k o c y t e s i s s h o wn i n t h e l e f t . F l u o r e s c e n c e a n a l y s i s wa s p e r f o r me d o n t h e g a t e d c e l l s . Re pr e s e n t a t i v e p r o f i l e s o f t wo -c o l o r f l o w c y t o me t r y a r e i n d i c a t e d i n t h e r i g h t . S mI g -κ a n d -λ , s u r f a c e me mb r a n e i mmu n o g l o b u l i n κ a n d λ l i g h t c h a i n s ; Cy I g -κ a n d -λ , c y t o p l a s mi c i mmu n o g l o b u l i n κ a n d λ l i g h t c h a i n s . E x a mi n a t i o n o f c i r c u l a t i n g CD1 0 + T -c e l l wa s n o t p e r f o r me d i n t h i s s t u d y .
Discussion
We reported here a patient with an advanced-stage lymphoma associated with a variety of hematological/immunological abnormalities. Although biopsy of the affected lymph nodes was not performed, histological appearance of the bone marrow as well as proliferation of polyclonal plasma cells in the peripheral blood led to the diagnosis of AITL. The postmortem pathology was consistent with progression of peripheral T-cell lymphoma. Bone marrow involvement has been found in as high as 60 to 90% of the cases with AITL (2, 4, 7). Bone marrow biopsy usually reveals a nodular or interstitial pattern of involvement (5, 6); therefore, complete replacement of hematopoietic tissues by AITL lesions in the present case is most
A number of autoimmune phenomena including circulating auto-antibodies have been reported in association with AITL (2, 3) . A low level of complement activity was found in 8 of 9 patients with AITL-related disorders (12 
